## CRM: Salesforce, Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 6.7% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($246.30)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Salesforce Inc. $CRM Stock Holdings Lowered by Vega Investment Solutions**
- Source: MarketBeat | 20251208T130819 | Somewhat-Bullish | Relevance: 99%
- Vega Investment Solutions significantly reduced its stake in Salesforce by 35.3% in Q2, selling 9,996 shares and retaining 18,297 shares valued at $4.99 million. Insider activity was mixed, with a director buying shares and the CEO selling some, while analysts maintain a "Moderate Buy" rating with an average target price of $326.54 for CRM. The company reported strong Q results, beating EPS expectations.

**2. Dir Morfit Buys 96,000 ($25M) Of Salesforce Inc [CRM]**
- Source: TradingView | 20251208T141427 | Neutral | Relevance: 99%
- Salesforce Inc. Director, G. Mason Morfit, purchased 96,000 shares of CRM stock on December 5, 2025, at a price of $260.58 per share, totaling over $25 million. This transaction increased Morfit's indirect holdings to 2,994,509 shares. The information was disclosed in a Form 4 filed with the SEC.

**3. Axa S.A. Has $336.22 Million Holdings in Salesforce Inc. $CRM**
- Source: MarketBeat | 20251209T083106 | Somewhat-Bullish | Relevance: 98%
-  Axa S.A. decreased its stake in Salesforce Inc. by 17% in the second quarter, now holding 1,232,978 shares valued at $336.22 million, making it their 13th largest position. Salesforce reported strong Q3 earnings, beating EPS expectations with $3.25 per share on $10.26 billion in revenue, and provided optimistic Q4 2026 guidance. Institutional ownership remains high at 80.43%, with major players like Vanguard and State Street increasing their positions, though insiders sold shares worth approximately $43.3 million in the last quarter.

**4. Daiwa Securities Group Inc. Increases Stake in Salesforce Inc. $CRM**
- Source: MarketBeat | 20251209T102903 | Somewhat-Bullish | Relevance: 98%
-  Daiwa Securities Group Inc. has significantly increased its stake in Salesforce Inc. (NYSE:CRM) by 23.4% in the second quarter, bringing its total holdings to 277,804 shares valued at over $75 million. This move is part of a broader trend of institutional investors adjusting their positions in Salesforce, alongside insider trading activity including a director's acquisition and another insider's sale of shares. The CRM provider recently reported strong quarterly earnings and announced a quarterly dividend, while analysts maintain a "Moderate Buy" consensus rating for the stock.

**5. Salesforce Inc – Guidance rises from the Informatica acquisition**
- Source: StocksBNB | 20251208T050833 | Bullish | Relevance: 98%
- Salesforce Inc. (CRM) beat expectations for 9M26 revenue and earnings, leading to a raised target price of US$382.00, up from US$364.00, by Phillip Securities Research. The company's acquisition of Informatica contributed to increased revenue growth and improved Subscription and Support figures. Consequently, Phillip Securities Research maintains a "BUY" rating for Salesforce.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 10)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Morgan Stanley | $398 | $405 | -2% |
| 2025-12-08 | Citigroup | $257 | $253 | +2% |
| 2025-12-05 | DA Davidson | $235 | $225 | +4% |
| 2025-12-04 | Truist Securiti | $380 | $400 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Morgan Stanley | main | Overweight |
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-05 | DA Davidson | main | Neutral |
| 2025-12-04 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 29 ($26.85M) |
| Sells | 31 ($1.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.5% (-0.5%)
- State Street Corpora: 5.2% (+0.3%)
- JPMORGAN CHASE & CO: 2.7% (+46.5%)
- Geode Capital Manage: 2.2% (+0.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 6 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +5.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.13 suggests fair value with growth premium. Quality metrics strong (margin 18%). Balance sheet: $2.2B free cash flow. Analyst sentiment negative (10 target cuts vs 6 raises). Insider buying signal ($26.9M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $248.5B |
| Beta | 1.25 |
| 52W Range | $221.96 - $367.09 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.13 |
| Forward P/E | 20.0 |
| Current P/E | 22.2 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.3% to 6.7% (+5.4% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (6.7% > 6.0%), caution on chasing. MRS_5 at 2.8% confirms short-term momentum alignment. Outperforming sector by 5.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.94), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 6.72% (CS: 95) | Strong |
| RSI_14 | 66.1 | Neutral |
| MACD Histogram | 3.94 | Bullish |
| vs SMA20 | 1.092x | Above |
| vs SMA50 | 1.069x | Above |
| vs SMA200 | 1.008x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $261.02
- **Stop Loss:** $246.30 (5.6% risk)
- **Target:** $275.74 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 81
- **Position Value:** $21,142.62
- **Portfolio %:** 21.14%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-25 (Est: $3.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.86 | $3.25 | +13.6% |
| 2025Q3 | $2.78 | $2.91 | +4.7% |
| 2025Q2 | $2.55 | $2.58 | +1.3% |
| 2025Q1 | $2.61 | $2.78 | +6.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*